nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—Gefitinib—EGFR—pharynx cancer	0.0949	1	CrCbGaD
Cisapride—HTR3A—vagus nerve—pharynx cancer	0.0918	0.225	CbGeAlD
Cisapride—HTR3A—cranial nerve—pharynx cancer	0.0699	0.172	CbGeAlD
Cisapride—HTR2A—trigeminal nerve—pharynx cancer	0.0396	0.0971	CbGeAlD
Cisapride—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0395	0.0795	CbGpPWpGaD
Cisapride—HTR2A—vagus nerve—pharynx cancer	0.037	0.0909	CbGeAlD
Cisapride—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0347	0.0697	CbGpPWpGaD
Cisapride—HTR2A—cranial nerve—pharynx cancer	0.0282	0.0692	CbGeAlD
Cisapride—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0222	0.0446	CbGpPWpGaD
Cisapride—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0194	0.0391	CbGpPWpGaD
Cisapride—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0188	0.0378	CbGpPWpGaD
Cisapride—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0165	0.0331	CbGpPWpGaD
Cisapride—HTR3A—brainstem—pharynx cancer	0.0154	0.0377	CbGeAlD
Cisapride—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0145	0.0291	CbGpPWpGaD
Cisapride—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0127	0.0255	CbGpPWpGaD
Cisapride—HTR2C—brainstem—pharynx cancer	0.0124	0.0304	CbGeAlD
Cisapride—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0121	0.0244	CbGpPWpGaD
Cisapride—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0111	0.0224	CbGpPWpGaD
Cisapride—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0106	0.0214	CbGpPWpGaD
Cisapride—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00976	0.0196	CbGpPWpGaD
Cisapride—DRD2—brainstem—pharynx cancer	0.00941	0.0231	CbGeAlD
Cisapride—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00898	0.0181	CbGpPWpGaD
Cisapride—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00878	0.0176	CbGpPWpGaD
Cisapride—HTR3A—head—pharynx cancer	0.0085	0.0209	CbGeAlD
Cisapride—HTR2A—neck—pharynx cancer	0.00812	0.0199	CbGeAlD
Cisapride—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00787	0.0158	CbGpPWpGaD
Cisapride—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0077	0.0155	CbGpPWpGaD
Cisapride—HTR2C—spinal cord—pharynx cancer	0.00769	0.0189	CbGeAlD
Cisapride—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0076	0.0153	CbGpPWpGaD
Cisapride—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00713	0.0143	CbGpPWpGaD
Cisapride—HTR2C—head—pharynx cancer	0.00684	0.0168	CbGeAlD
Cisapride—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00679	0.0136	CbGpPWpGaD
Cisapride—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.00674	0.0136	CbGpPWpGaD
Cisapride—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00667	0.0134	CbGpPWpGaD
Cisapride—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.00654	0.0131	CbGpPWpGaD
Cisapride—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.00645	0.013	CbGpPWpGaD
Cisapride—HTR2B—head—pharynx cancer	0.00642	0.0158	CbGeAlD
Cisapride—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00624	0.0125	CbGpPWpGaD
Cisapride—HTR2A—brainstem—pharynx cancer	0.00621	0.0152	CbGeAlD
Cisapride—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00619	0.0124	CbGpPWpGaD
Cisapride—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00595	0.012	CbGpPWpGaD
Cisapride—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00591	0.0119	CbGpPWpGaD
Cisapride—KCNH2—spinal cord—pharynx cancer	0.00577	0.0141	CbGeAlD
Cisapride—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.00566	0.0114	CbGpPWpGaD
Cisapride—CYP2D6—brainstem—pharynx cancer	0.00566	0.0139	CbGeAlD
Cisapride—HTR2A—epithelium—pharynx cancer	0.00553	0.0136	CbGeAlD
Cisapride—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00547	0.011	CbGpPWpGaD
Cisapride—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00543	0.0109	CbGpPWpGaD
Cisapride—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00531	0.0107	CbGpPWpGaD
Cisapride—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00529	0.0106	CbGpPWpGaD
Cisapride—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00527	0.0106	CbGpPWpGaD
Cisapride—CYP2B6—lymphoid tissue—pharynx cancer	0.00522	0.0128	CbGeAlD
Cisapride—DRD2—head—pharynx cancer	0.0052	0.0128	CbGeAlD
Cisapride—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.00518	0.0104	CbGpPWpGaD
Cisapride—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00516	0.0104	CbGpPWpGaD
Cisapride—KCNH2—head—pharynx cancer	0.00512	0.0126	CbGeAlD
Cisapride—HTR2A—trachea—pharynx cancer	0.00489	0.012	CbGeAlD
Cisapride—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00477	0.00959	CbGpPWpGaD
Cisapride—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00466	0.00937	CbGpPWpGaD
Cisapride—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00464	0.00932	CbGpPWpGaD
Cisapride—HTR2B—lymph node—pharynx cancer	0.0045	0.011	CbGeAlD
Cisapride—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00447	0.00898	CbGpPWpGaD
Cisapride—CYP2B6—head—pharynx cancer	0.00421	0.0103	CbGeAlD
Cisapride—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00418	0.00841	CbGpPWpGaD
Cisapride—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00409	0.00822	CbGpPWpGaD
Cisapride—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00408	0.0082	CbGpPWpGaD
Cisapride—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00404	0.00812	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00399	0.00801	CbGpPWpGaD
Cisapride—HTR2A—spinal cord—pharynx cancer	0.00386	0.00947	CbGeAlD
Cisapride—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00367	0.00737	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00363	0.00731	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.0036	0.00725	CbGpPWpGaD
Cisapride—KCNH2—lymph node—pharynx cancer	0.00359	0.0088	CbGeAlD
Cisapride—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00358	0.00719	CbGpPWpGaD
Cisapride—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00354	0.00712	CbGpPWpGaD
Cisapride—HTR2A—head—pharynx cancer	0.00343	0.00841	CbGeAlD
Cisapride—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00332	0.00667	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00329	0.00661	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00316	0.00635	CbGpPWpGaD
Cisapride—CYP2D6—head—pharynx cancer	0.00313	0.00767	CbGeAlD
Cisapride—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00311	0.00624	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00291	0.00584	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00288	0.00579	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00281	0.00565	CbGpPWpGaD
Cisapride—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00278	0.00559	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00246	0.00495	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.0024	0.00482	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00217	0.00436	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.0019	0.00382	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.00122	0.00245	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00121	0.00243	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00121	0.00243	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00112	0.00225	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ADH7—pharynx cancer	0.0011	0.00222	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ADH7—pharynx cancer	0.00101	0.00203	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000999	0.00201	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000967	0.00194	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000924	0.00186	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000902	0.00181	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.000887	0.00178	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000882	0.00177	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.000847	0.0017	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000816	0.00164	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000806	0.00162	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000797	0.0016	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000764	0.00154	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—EGFR—pharynx cancer	0.000737	0.00148	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000715	0.00144	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.0007	0.00141	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000699	0.00141	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000691	0.00139	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000684	0.00137	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000682	0.00137	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000668	0.00134	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—pharynx cancer	0.00063	0.00127	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000627	0.00126	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000622	0.00125	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000616	0.00124	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000606	0.00122	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000579	0.00116	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000567	0.00114	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000562	0.00113	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—CCND1—pharynx cancer	0.000555	0.00111	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000541	0.00109	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000531	0.00107	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000517	0.00104	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000497	0.001	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000493	0.000991	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00048	0.000966	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000475	0.000955	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000471	0.000947	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EGFR—pharynx cancer	0.000435	0.000875	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000421	0.000847	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.00041	0.000824	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000403	0.000809	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000371	0.000745	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—pharynx cancer	0.000365	0.000734	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000325	0.000654	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000311	0.000625	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—EGFR—pharynx cancer	0.000289	0.000581	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—pharynx cancer	0.000233	0.000469	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—pharynx cancer	0.000218	0.000438	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—pharynx cancer	0.000206	0.000414	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—pharynx cancer	0.000203	0.000407	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—pharynx cancer	0.000176	0.000353	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—pharynx cancer	0.000171	0.000343	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—pharynx cancer	0.000155	0.000312	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—pharynx cancer	0.000152	0.000307	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—pharynx cancer	0.000143	0.000288	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—pharynx cancer	0.000138	0.000277	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—pharynx cancer	0.000122	0.000244	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—pharynx cancer	0.00012	0.000241	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—pharynx cancer	0.000116	0.000233	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—pharynx cancer	0.000102	0.000205	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—pharynx cancer	0.0001	0.000202	CbGpPWpGaD
